跳轉至內容
Merck
  • Uptake and effects of a mixture of widely used therapeutic drugs in Eruca sativa L. and Zea mays L. plants.

Uptake and effects of a mixture of widely used therapeutic drugs in Eruca sativa L. and Zea mays L. plants.

Ecotoxicology and environmental safety (2014-07-22)
Milena Marsoni, Fabrizio De Mattia, Massimo Labra, Antonia Bruno, Antonella Bruno, Marcella Bracale, Candida Vannini
摘要

Pharmaceutically active compounds (PACs) are continuously dispersed into the environment due to human and veterinary use, giving rise to their potential accumulation in edible plants. In this study, Eruca sativa L. and Zea mays L. were selected to determine the potential uptake and accumulation of eight different PACs (Salbutamol, Atenolol, Lincomycin, Cyclophosphamide, Carbamazepine, Bezafibrate, Ofloxacin and Ranitidine) designed for human use. To mimic environmental conditions, the plants were grown in pots and irrigated with water spiked with a mixture of PACs at concentrations found in Italian wastewaters and rivers. Moreover, 10× and 100× concentrations of these pharmaceuticals were also tested. The presence of the pharmaceuticals was tested in the edible parts of the plants, namely leaves for E. sativa and grains for Z. mays. Quantification was performed by liquid chromatography mass spectroscopy (LC/MS/MS). In the grains of 100× treated Z. mays, only atenolol, lincomycin and carbamazepine were above the limit of detection (LOD). At the same concentration in E. sativa plants the uptake of all PACs was >LOD. Lincomycin and oflaxacin were above the limit of quantitation in all conditions tested in E. sativa. The results suggest that uptake of some pharmaceuticals from the soil may indeed be a potential transport route to plants and that these environmental pollutants can reach different edible parts of the selected crops. Measurements of the concentrations of these pharmaceuticals in plant materials were used to model potential adult human exposure to these compounds. The results indicate that under the current experimental conditions, crops exposed to the selected pharmaceutical mixture would not have any negative effects on human health. Moreover, no significant differences in the growth of E. sativa or Z. mays plants irrigated with PAC-spiked vs. non-spiked water were observed.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
卡马西平, powder
Sigma-Aldrich
阿替洛尔, ≥98% (TLC), powder
Sigma-Aldrich
氧氟沙星, fluoroquinolone antibiotic
Sigma-Aldrich
林可霉素 盐酸盐, 96.0-102.0% (HPLC)
Sigma-Aldrich
雷尼替丁 盐酸盐, solid
Sigma-Aldrich
苯扎贝特, ≥98%, solid
Supelco
卡马西平标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
林可霉素 盐酸盐, ≥90% (TLC)
USP
氧氟沙星, United States Pharmacopeia (USP) Reference Standard
Supelco
硫酸舒喘灵, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
氧氟沙星, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
林可霉素 盐酸盐, BioReagent, suitable for cell culture
USP
卡马西平, United States Pharmacopeia (USP) Reference Standard
Supelco
阿替洛尔标准溶液 溶液, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
卡马西平, Pharmaceutical Secondary Standard; Certified Reference Material
USP
阿替洛尔, United States Pharmacopeia (USP) Reference Standard
Supelco
卡马西平, analytical standard
Sigma-Aldrich
沙丁胺醇 半硫酸盐, ≥98%
USP
雷尼替丁 盐酸盐, United States Pharmacopeia (USP) Reference Standard
USP
林可霉素 盐酸盐 一水合物, United States Pharmacopeia (USP) Reference Standard
Supelco
雷尼替丁 盐酸盐, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
林可霉素 盐酸盐 一水合物, VETRANAL®, analytical standard
沙丁胺醇 半硫酸盐, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
卡马西平, meets USP testing specifications
卡马西平, European Pharmacopoeia (EP) Reference Standard
林可霉素 盐酸盐 一水合物, European Pharmacopoeia (EP) Reference Standard
Supelco
氧氟沙星, VETRANAL®, analytical standard
氧氟沙星, European Pharmacopoeia (EP) Reference Standard
雷尼替丁 盐酸盐, European Pharmacopoeia (EP) Reference Standard
苯扎贝特, European Pharmacopoeia (EP) Reference Standard